HYTERA-COMMUNICATIONS
15.5.2023 12:55:30 CEST | Business Wire | Press release
Hytera Communications (SZSE: 002583), a leading global provider of professional communications technologies and solutions, gathered its distribution, project, and application partners from over 50 countries and regions and successfully held Hytera Global Partner Summit (HGPS) 2023 on May 11th in Bali, Indonesia.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230515005390/en/
Yelin Jiang, CEO of Hytera Group, delivering the keynote speech (Photo: Business Wire)
HGPS serves as a platform for Hytera partners to network with other like-minded professionals, gain insights into the latest trends of the industry, and learn what’s new with Hytera, including new products, solutions, and policies. The year 2023 marks the 30th anniversary of the company; therefore, HGPS 2023 was also a venue for the retrospect and celebration of the common journey shared by Hytera and its partners from across the world.
“The past 30 years have seen Hytera rose against numerous challenges and evolved from a product provider to a technology and solution provider. Now we are one of the leading companies in mission-critical and business-critical communications. Our talented engineers working in 8 R&D facilities across the world are the source of our confidence in future growth,” said Yelin Jiang, CEO of Hytera Group, in the keynote speech. “In 2022, Hytera released many innovative new products across multiple product series such as DMR radios, MCS & PoC radios, and body cameras. The new-generation H Series DMR radio was an instant success in the market.”
Thomas Lynch, executive research director of Omdia, was present to share the latest industry trends and developments with attendees, providing insights into the ever-changing industry landscape. According to Omdia’s analysis, in response to the market demands for data-rich features, Mission Critical Communications are moving towards a hybrid approach: keeping trusted LMR technology, such as TETRA, DMR, PDT for the indispensable voice communication in extreme situations and empowering the additional services and features with integrated LTE Broadband solutions. This is manifested in Hytera’s multi-front product development strategy.
Fully leveraging the venue of HGPS, Hytera brought regional partners into a global perspective with product solution deep dives and partners’ case studies. At the exhibition area, a complete portfolio of Hytera products and solutions were showcased, including TETRA Radios and Systems, DMR Radios and Systems, MCS & PoC Radios and Solutions, Body Camera Solutions, Multimedia Communication Platform, Control Room Solutions, 4G&5G Systems, and Fast Deployment Solutions. HGPS2023 invited some of Hytera ecosystem partners to showcase their value-added applications on top of Hytera products and they brought solutions such as encryptions, dispatching, satellite connectivity, and emergency coordination.
The Summit concluded on a high note with the Hytera 30th Anniversary and Awarding Ceremony, which acknowledged the performance and progress of partners in the year 2022. Golden Loyalty Awards was specially set up for HGPS2023 to celebrate the long-term partnership with and loyalty to the Hytera brand in the past three decades.
About Hytera
Hytera Communications Corporation Limited (SZSE: 002583) is a leading global provider of professional communications technologies and solutions. With voice, video and data capabilities, we provide faster, safer, and more versatile connectivity for business and mission critical users. We make the world more efficient and safer by enabling our customers to achieve more in both daily operations and emergency response. Learn more at https://www.hytera.com/en/home.html.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230515005390/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Galderma Provides Progress Update Regarding RelabotulinumtoxinA Regulatory Submission in the United States1.7.2026 07:00:00 CEST | Press release
Galderma received a Complete Response Letter from the FDA with comments related to observations during manufacturing site inspection and analytical method optimization Relfydess is approved in 33 markets and already launched in more than 20, including across Europe, the Middle East and Australia, with an encouraging early launch trajectory supported by positive healthcare professional feedback Regulatory filings in other territories are ongoing and remain on track Ad hoc announcement pursuant to Art. 53 LR Galderma (SIX: GALD) today provided progress updates regarding the regulatory review of its pending Biologics License Application (“BLA”) for RelabotulinumtoxinA with the U.S. Food and Drug Administration (“FDA”). The Company has received a Complete Response Letter (CRL) from the FDA with comments related to observations during manufacturing site inspection and analytical method optimization. As part of its review, the FDA conducted a Pre-License Inspection (PLI) of Galderma’s manufa
EVE Energy Showcases All-Scenario Energy Storage Solutions at The Smarter E Europe 20261.7.2026 03:45:00 CEST | Press release
EVE Energy unveiled its Mr. Big Family series, a 6.9+ MWh energy storage system, and all-scenario energy storage solutions at Intersolar Europe in Munich. Drawing on traceable large-cell technology, proven large-scale energy storage project delivery experience, and global delivery capabilities, the company is addressing Europe's diverse energy storage requirements across utility-scale, commercial & industrial (C&I ), and data center segments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260630889717/en/ EVE Energy showcases its Mr. Giant 3.0 6.9+ MWh energy storage system at The Smarter E Europe 2026 in Munich, Germany Advancing Large-Cell Technology with Global Project Validation As one of the first companies to focus on large-capacity energy storage cells, EVE Energy has iteratively upgraded its cell platform from 560 Ah and 628 Ah to 702 Ah, adhering to a stacking process route throughout. At the exhibition, the Mr. Gia
Bending Spoons S.p.A. announces pricing of initial public offering1.7.2026 01:56:00 CEST | Press release
Bending Spoons S.p.A. (“Bending Spoons”), a leading technology company, today announces the pricing of its initial public offering (“IPO”) at $29.00 per share. A total of 57,971,015 ordinary shares are being offered, of which 34,398,640 shares are being offered by Bending Spoons and 23,572,375 shares are being offered by certain selling shareholders (the “Selling Shareholders”). Bending Spoons will not receive any proceeds from any sale of shares by the Selling Shareholders. The shares are expected to begin trading on the Nasdaq Global Select Market under the ticker symbol “BSP” on July 1, 2026. The offering is expected to close on July 2, 2026, subject to customary closing conditions. In addition, Bending Spoons and the Selling Shareholders granted the underwriters an option to purchase up to an additional 5,244,026 ordinary shares from Bending Spoons and up to an additional 3,451,626 ordinary shares from the Selling Shareholders at the initial public offering price, less underwriting
FDA Issues Modified Risk Tobacco Product Orders for 20 ZYN Nicotine Pouch Products30.6.2026 18:19:00 CEST | Press release
FDA’s decision makes ZYN the first nicotine pouch product to receive MRTP orders authorizing reduced-risk claims versus cigarettes Philip Morris International Inc. (PMI) (NYSE: PM) today announced that the U.S. Food and Drug Administration (FDA) issued Modified Risk Tobacco Product (MRTP) orders for 20 variants of ZYN nicotine pouch products. These are the first MRTP orders granted for nicotine pouches, allowing PMI U.S. to market the following claim for the authorized ZYN products: “Using ZYN instead of cigarettes puts you at a lower risk of mouth cancer, heart disease, lung cancer, stroke, emphysema, and chronic bronchitis.” “FDA’s decision is an important moment for the more than 45 million legal-age nicotine consumers in America,” saidStacey Kennedy, PMI U.S. CEO. “Today’s news ensures these adultshave access to accurate, science-based information, including FDA-authorized evidence that switching from cigarettes to ZYN reduces the risk of smoking-related diseases like heart disease
Caidya Announces Strategic Combination with Simbec-Orion Bridging Early Scientific Insight and Global Clinical Execution30.6.2026 17:00:00 CEST | Press release
Caidya today announced a strategic combination with Simbec-Orion designed to close the divide between early scientific insight and global clinical execution. The combination of Caidya and Simbec-Orion creates a differentiated specialty clinical CRO platform that enables programs to scale, maintaining focus, speed, and accountability. The strategic combination brings together complementary strengths to create a more complete development partner for innovative biopharma companies. With established operations across Europe, the Americas, APAC, and China, the combined organization provides meaningful expertise and execution capabilities in the regions that matter most. Simbec-Orion brings early-phase clinical pharmacology capabilities alongside deep therapeutic expertise for later stage complex oncology and rare disease trials, helping sponsors shape critical decisions early in the development lifecycle. Together, the organizations strengthen their ability to support complex, cross-border
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom